Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Parkinson's disease clinical research Stories

2014-04-03 12:30:25

LONDON, April 3, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Parkinson's Disease Therapeutics Market to 2019 - Pipeline Shows Shift Towards Long Term Disease Management Parkinson's Disease Therapeutics Market to 2019 - Pipeline Shows Shift Towards Long Term Disease Management SummaryGBI Research has released the pharma report "Parkinson's Disease Therapeutics Market to 2019 - Pipeline Shows Shift Towards Long Term Disease Management". The...

2014-03-31 12:28:21

NEW YORK, March 31, 2014 /PRNewswire-USNewswire/ -- Results out of a study funded by The Michael J. Fox Foundation for Parkinson's Research (MJFF) have enabled researchers to secure a $23 million grant from the National Institutes of Health (NIH), continuing a repurposed drug approved for hypertension to Phase III testing for slowing Parkinson's progression. The trial investigating the compound isradipine will be the most advanced, current study into a disease-modifying therapy for...

2014-03-28 16:22:24

Supports Partnerships Between Patient Advocates and Scientists at Four Leading Parkinson's Research Centers NEW YORK, March 28, 2014 /PRNewswire-USNewswire/ -- The Parkinson's Disease Foundation® (PDF®) is pleased to announce $20,000 in grant funding to support patient-centered research at four leading Parkinson's disease research institutions. The grants are provided through PDF's first Parkinson's Advocates in Research (PAIR) Leadership Awards. These awards support partnerships...

2014-03-12 12:28:22

I'm In campaign to educate underrepresented populations about clinical trial participation WASHINGTON, March 12, 2014 /PRNewswire/ -- The Pharmaceutical Research and Manufacturers of America (PhRMA) and the National Minority Quality Forum today announced a first-of-its-kind national campaign to help increase diversity in clinical trials. The I'm In campaign will raise awareness about the importance of clinical research and encourage greater participation by diverse patient...

2014-03-07 12:26:20

Volunteer Network Has Track Record of Improving Trial Recruitment, Removing Research Roadblocks NEW YORK, March 7, 2014 /PRNewswire-USNewswire/ -- The Parkinson's Disease Foundation® (PDF®) invites research professionals within industry, academia and government, to partner with its trained patient advocates to bring about better treatments for Parkinson's disease. This week, PDF welcomes new members to its national network, which now includes more than 230 Research Advocates whose...

2013-12-26 12:21:02

Potential Neuroprotective Therapy Ready for Next Stage of Development after Michael J. Fox Foundation Funding NEW YORK, Dec. 26, 2013 /PRNewswire-USNewswire/ -- New findings published in JAMA Neurology from research into a potentially protective therapy for Parkinson's disease (PD) show that with medical supervision, urate levels may safely be raised while mitigating risk of complications such as gout. Previous research showed that higher levels of the antioxidant urate were...

2013-11-13 12:27:34

Online tool now a global resource to clinical teams and trial volunteers NEW YORK, Nov. 13, 2013 /PRNewswire-USNewswire/ -- Today, The Michael J. Fox Foundation for Parkinson's Research (MJFF) launches its clinical research matching tool Fox Trial Finder (www.foxtrialfinder.org) globally. Previously limited to five English-speaking countries, Fox Trial Finder is now accessible to both trial volunteers and clinical teams across the globe, increasing both the number of Parkinson's...

2013-10-16 12:24:04

Event Aims to Educate on Local Opportunities to Join the Pursuit for a Cure NEW YORK, Oct. 16, 2013 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) will host a Clinical Trials Fair in New York City on Saturday, October 19, to raise awareness and understanding of local Parkinson's research opportunities among patients, their families and friends, and other interested volunteers. "I am grateful to the researchers, neurologists and everyone in...

2013-10-03 16:23:03

NEW BRUNSWICK, N.J., Oct. 3, 2013 /PRNewswire-USNewswire/ -- Research being performed by Durin Technologies, Inc., exploring the development of a novel blood test for Parkinson's disease was recently awarded a second grant from The Michael J. Fox Foundation for Parkinson's Research. Durin, a company that received seed funding from Foundation Venture Capital Group, LLC, developed the test that could mean quicker diagnosis and faster drug development for Parkinson's patients. "Using current...

2013-09-26 08:25:49

NEW YORK, Sept. 26, 2013 /PRNewswire-USNewswire/ -- Tonight, Michael J. Fox returns to television as the star of his own sitcom after more than two decades living with Parkinson's disease. Fox's decision to return to primetime has injected Parkinson's into the national conversation -- a conversation already transformed by The Michael J. Fox Foundation for Parkinson's Research (MJFF), which the actor launched in 2000 with the exclusive goal of funding research to speed a cure for the...